Australia: from October 1, 2024, Individuals Using E-cigarettes for Treatment No Longer Need Prescription

Regulations by 2FIRSTS.ai
Jun.25.2024
Australia: from October 1, 2024, Individuals Using E-cigarettes for Treatment No Longer Need Prescription
Australian Health Minister Mark Butler announced that the Senate is set to pass a bill banning recreational e-cigarette use.

According to an announcement on the official website of the Australian Department of Health on June 25th, Australian Health Minister Mark Butler declared that the Senate is set to pass a bill that will completely ban the use of recreational e-cigarettes.

 

Starting from July 1st, only therapeutic e-cigarettes can be sold, and they can only be sold through pharmacies.

 

In addition, starting from October 1, 2024, individuals who want to use e-cigarettes for treatment will no longer need a prescription. Instead, they will be able to purchase e-cigarettes directly from pharmacies, with the products being kept behind the counter. Customers will only need to show identification to prove they are over 18 years old in order to make a purchase.

 

Butler stated in a press conference on Tuesday (the 25th)

 

Now, since the first time I announced our intentions in this field, I have been very clear that we are determined to return e-cigarettes to their original purpose: a therapeutic product. I have stated that in Australia, e-cigarettes can only be legally purchased through pharmacies as therapeutic products. It has been revealed that when legislation is submitted to the Senate this week, the government will propose amendments to allow legally compliant e-cigarettes, meeting standards set by the Therapeutic Goods Administration (TGA), to be purchased not only with a doctor's prescription from pharmacies, but also as so-called "Schedule 3" medicines from October 1. This is a very common therapeutic pathway that allows certain medicines (such as emergency contraceptives, pseudoephedrine, various asthma medications) to be obtained through discussion with a pharmacist (not a retail assistant or pharmacy assistant).

 

Butler has expressed the government's determination to eliminate the recreational use of e-cigarettes in Australia, particularly emphasizing the need to take e-cigarettes away from children. He pointed out that approximately one-sixth of high school students are using e-cigarettes, and about a quarter of young people in their teens and twenties are also using e-cigarettes. He emphasized that e-cigarettes are insidious devices designed to addict a new generation to nicotine.

 

The minister stated that this is the third wave of e-cigarette reform. The first wave occurred on January 1st of this year, when he proposed an import control measure banning the entry of any disposable e-cigarettes into Australia. Since the implementation of this ban, the border forces have seized over 2.5 million e-cigarettes in just a few months.

 

The second wave, which came into effect in March this year, dictates that non-therapeutic e-cigarettes will be more broadly prohibited from sale and supply. In order to implement and enforce this ban, the Therapeutic Goods Administration (TGA) has established very clear standards for the sale of e-cigarettes in Australia.

 

The third wave of reforms will be submitted to the Senate this week and, if passed, the sale and supply of e-cigarettes outside of pharmacies will be prohibited starting next Monday, July 1st. Butler noted that this has received support from all health ministers in every jurisdiction, whether controlled by the Liberal or Labor Party. He stated that he is determined to see it pass this week.

 

When asked about why e-cigarettes will not require a prescription starting October 1st after requiring one from July 1st, the minister explained that the aim is to ensure pharmacists can receive the best guidance on how to handle these new laws.

 

Since the end of last year, doctors have been receiving these recommendations. We have funded the General Practitioners Association to update their members' clinical guidelines, starting at the end of last year. Visits to doctors have been significantly expanded since January 1, reflecting the timing of the import ban. Therefore, we are very confident that we have established a good arrangement to support general practitioners. Now we want to ensure that we have a similar arrangement to support pharmacists, and the three-month transition period will allow us to do so.

 

In addition, the minister also emphasized the upcoming e-cigarette law revisions at this press conference, including strict advertising restrictions and amendments allowing direct marketing to pharmacists. They pledged to increase resources for smoking cessation services, especially targeting the issue of nicotine addiction among young people, including promotional and informational measures on social media.

 

At the same time, he emphasized that the Australian government will not intervene in the pricing of e-cigarettes, viewing it as a matter for the private market, but also underscored the government's commitment to legal enforcement and resource support.

 

Finally, the minister rebutted the opposition party's proposed tax and regulation plan on e-cigarettes, pointing out that these policies may not be in line with reality and past international experiences, while criticizing the opposition party's attitudes towards tobacco and e-cigarette control.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
An October 2026 review of U.S. state vapor product directories found KUMI 6 SCENIC 50K listed in Louisiana and Nebraska. Louisiana classifies 20 related product entries as “FDA EXEMPTION.” The SCENIC platform is marketed in both conventional nicotine-salt and NoNic6 formulations, each advertised with 22mL e-liquid capacity and up to 50,000 puffs. U.S. wholesaler Midwest Goods listed both versions in August 2025 with a suggested retail price of $19.99 each. The NoNic6 version is associated with 6-methylnicotine and is also marketed by some distributors as “nicotine-free.”
product
Oct.27
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canadian Health Minister Marjorie Michel says she is not considering loosening retail restrictions on nicotine pouches. Canada regulates pouches containing 4 mg or less of nicotine per unit as non-prescription nicotine replacement therapy and requires newer NRT formats such as pouches to be sold from behind pharmacy counters. Meanwhile, Unsmoke Canada, linked to Philip Morris International's Canadian business, is pushing to allow pouches in convenience stores and other general retail outlets. Health Canada also acknowledges continued unauthorized sales, while recent research shows rising pouch use among Canadian youth aged 16 to 19.
Sep.24
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
IVG Parent Secures HMRC Excise Warehouse and Duty Stamp Approvals Ahead of UK Vape Tax
IVG Parent Secures HMRC Excise Warehouse and Duty Stamp Approvals Ahead of UK Vape Tax
Acme Vape Ltd, the company behind UK vaping brand IVG, has received HM Revenue & Customs approval to operate an excise warehouse for vaping products and participate in the Vaping Duty Stamps Scheme. The UK's Vaping Products Duty will take effect on October 1, 2026, at a flat rate of £2.20 per 10ml of vaping liquid. Acme Vape Ltd says its approved warehouse in Preston will become operational under the new regime on the same date.
Regulations
Sep.18 by 2Firsts Perspectives
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
Latest UK ONS Data: 54% of Vapers Are Former Cigarette Smokers, 26% Also Smoke and 20% Never Smoked Regularly
Latest UK ONS Data: 54% of Vapers Are Former Cigarette Smokers, 26% Also Smoke and 20% Never Smoked Regularly
Former cigarette smokers accounted for an estimated 54% of current e-cigarette users in Great Britain in 2025, while 26% also smoked cigarettes and 20% had never regularly smoked, according to a 2Firsts analysis of Office for National Statistics (ONS) data. Among former cigarette smokers who currently vape, approximately 81% used e-cigarettes daily, compared with about 50% of dual users. The ONS found that 33.8% of current cigarette smokers also vaped in 2025, up from 10.6% in 2014. Approximately 1.1 million adults who had never regularly smoked cigarettes used e-cigarettes, representing 2.9% of that population, compared with 0.2% in 2014. The figures highlight differences in the composition, frequency of use and long-term trends across Britain's vaping population.
DATA
Oct.14